Cargando…
Role of MicroRNA-223 and MicroRNA-182 as Novel Biomarkers in Early Detection of Colorectal Cancer
BACKGROUND: Colorectal cancer is a common and lethal disease. It is estimated that approximately 145,600 new cases of large bowel cancer are diagnosed annually in the USA. MiRNA-223 and miRNA-182 have been reported in various cancers, such as lung, gastric, breast and colorectal cancer and proposed...
Autores principales: | Mahmoud, Hala A, El Amin, Hussein Ahmed, Ahmed, Ehab Saleh Mahmoud, Kenawy, Ahmed Gaber, El-Ebidi, Abdallah M, ElNakeeb, Islam, Kholef, Emad Farah Mohammed, Elsewify, Wael Abd Elgwad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964337/ https://www.ncbi.nlm.nih.gov/pubmed/35368799 http://dx.doi.org/10.2147/IJGM.S353244 |
Ejemplares similares
-
Potential role of plasma miR-21 and miR-92a in distinguishing between irritable bowel syndrome, ulcerative colitis, and colorectal cancer
por: Ahmed Hassan, Elham, et al.
Publicado: (2020) -
Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma
por: Golbakhsh, Mohammad Reza, et al.
Publicado: (2016) -
MicroRNA-183/96/182 cluster in immunity and autoimmunity
por: Wang, Zhuang, et al.
Publicado: (2023) -
Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
por: Ali, Omaima Mohamed, et al.
Publicado: (2020) -
Bone protection by inhibition of microRNA-182
por: Inoue, Kazuki, et al.
Publicado: (2018)